139 related articles for article (PubMed ID: 30810895)
1. The Haphazard Pattern in Grade-3 Endometrioid Carcinoma Is Associated with Poor Prognosis and Tumor Lymphocyte Infiltration.
Miyamoto M; Takano M; Tsuda H; Matsuura H; Sakamoto T; Takasaki K; Kato K; Soyama H; Aoyama T; Ishibashi H; Iwahashi H; Furuya K
Pathol Oncol Res; 2020 Apr; 26(2):783-790. PubMed ID: 30810895
[TBL] [Abstract][Full Text] [Related]
2. Zone Formation of Lymphocyte Infiltration at Invasive Front as a Biomarker of Prognosis in Endometrial Carcinomas.
Miyamoto M; Takano M; Tsuda H; Matuura H; Aoyama T; Soyama H; Kato K; Iwahashi H; Ishibashi H; Yoshikawa T; Suzuki A; Hirata J; Furuya K
Oncology; 2019; 96(2):93-100. PubMed ID: 30282081
[TBL] [Abstract][Full Text] [Related]
3. Zone Formation of Lymphocyte Infiltration at the Invasive Front Results in the Prolonged Survival of Individuals With Endometrial Serous Carcinoma and Endometrioid Carcinoma With Serous Component.
Miyamoto M; Takano M; Tsuda H; Ishibashi H; Soyama H; Matsuura H; Sakamoto T; Aoyama T; Iwahashi H; Furuya K
Anticancer Res; 2019 Apr; 39(4):2085-2089. PubMed ID: 30952753
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
5. A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes.
Miyamoto M; Hada T; Ishibashi H; Iwahashi H; Kakimoto S; Suzuki R; Sakamoto T; Matsuura H; Tsuda H; Takano M
Anticancer Res; 2021 Feb; 41(2):1047-1053. PubMed ID: 33517314
[TBL] [Abstract][Full Text] [Related]
6. Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients.
Park JY; Nam JH; Kim YT; Kim YM; Kim JH; Kim DY; Sohn I; Lee SW; Sung CO; Kim KR
Virchows Arch; 2013 Mar; 462(3):289-96. PubMed ID: 23417747
[TBL] [Abstract][Full Text] [Related]
7. The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations.
Willvonseder B; Stögbauer F; Steiger K; Jesinghaus M; Kuhn PH; Brambs C; Engel J; Bronger H; Schmidt GP; Haller B; Weichert W; Keller G; Noske A; Pfarr N; Boxberg M
Cancer Immunol Immunother; 2021 Jun; 70(6):1679-1689. PubMed ID: 33340331
[TBL] [Abstract][Full Text] [Related]
8. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages.
Kono-Sato T; Miyai K; Yamagishi Y; Miyamoto M; Takano M; Matsukuma S; Sato K; Tsuda H
BMC Cancer; 2022 Apr; 22(1):361. PubMed ID: 35366828
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
10. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
Quick CM; May T; Horowitz NS; Nucci MR
Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
[TBL] [Abstract][Full Text] [Related]
11. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the infiltrative pattern invasion in endometrioid adenocarcinoma of the endometrium.
Suzuki C; Matsumoto T; Sonoue H; Arakawa A; Furugen Y; Kinoshita K
Pathol Int; 2003 Aug; 53(8):495-500. PubMed ID: 12895227
[TBL] [Abstract][Full Text] [Related]
14. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
Fadare O; Parkash V
Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
16. CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas.
Pascual-García M; Bértolo C; Nieto JC; Serrat N; Espinosa Í; D'Angelo E; Muñoz R; Rovira R; Vidal S; Prat J
Hum Pathol; 2016 Oct; 56():180-8. PubMed ID: 27346574
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
[TBL] [Abstract][Full Text] [Related]
18. Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Tsuda H; Takano M
J Ovarian Res; 2021 Feb; 14(1):33. PubMed ID: 33583413
[TBL] [Abstract][Full Text] [Related]
19. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
20. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
